Continuation Sessions of Mindfulness‐Based Cognitive Therapy (MBCT‐C) vs. Treatment as Usual in Late‐Life Depression and Anxiety: An Open‐Label Extension Study
Elena Dikaios, Sophia Escobar, Marouane Nassim, Chien-Lin Su, S. G. Torres-Platas, Soham Rej
International Journal of Geriatric Psychiatry June 11, 2020 DOI: 10.1002/gps.5360 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Older adults with late-life depression and anxiety |
| Topics | Anxiety Depression Meditation |
| Key findings | The published trial showed that MBCT improves symptoms of late-life depression and anxiety. The current analysis examines whether continuation sessions of MBCT prevent symptom recurrence, but no results are reported in the abstract. |
Abstract
Mindfulness‐based cognitive therapy (MBCT) is a novel treatment for depression. Our published randomized controlled trial shows that MBCT improves symptoms of late‐life depression (LLD) and anxiety (LLA). We now examine whether continuation sessions of MBCT (MBCT‐C) can prevent LLD/LLA symptom recurrence.